Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lucile Lefevre"'
BACKGROUND Prostate cancer is the second most common cancer in men. Due to medical advances and early diagnosis, long-term well-being and health-related quality of life (HRQoL) have become more important nowadays. OBJECTIVE We performed an observatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f9b9d00f0bdf78c99c1431a6f8dc86e
https://doi.org/10.2196/preprints.42973
https://doi.org/10.2196/preprints.42973
Autor:
Adèle L'Hostis, Jean-Louis Palgen, Nicoletta Ceres, Angelique Perrillat-Mercerot, Emmanuel Peyronnet, Evgueni Jacob, Riad Kahoul, Matthieu Coudron, Lucile Lefevre, Raphael Toueg, Andreea Todea, Marc Hommel, Jean-Pierre Boissel, Jim Bosley, Michaël Duruisseaux, Claudio Monteiro
Publikováno v:
Journal of Clinical Oncology. 40:e20565-e20565
e20565 Background: Tumor heterogeneity and treatment resistance remains a continued threat to patients with advanced non-small cell lung cancer (NSCLC), despite the emergence of targeted medicines, e.g. against epidermal growth factor receptor (EGFR)
Autor:
Adèle L’Hostis, Jean-Louis Palgen, Angélique Perrillat-Mercerot, Emmanuel Peyronnet, Evgueni Jacob, James Bosley, Michaël Duruisseaux, Raphaël Toueg, Lucile Lefèvre, Riad Kahoul, Nicoletta Ceres, Claudio Monteiro
Publikováno v:
npj Systems Biology and Applications, Vol 9, Iss 1, Pp 1-13 (2023)
Abstract Lung adenocarcinoma (LUAD) is associated with a low survival rate at advanced stages. Although the development of targeted therapies has improved outcomes in LUAD patients with identified and specific genetic alterations, such as activating
Externí odkaz:
https://doaj.org/article/3e54093f844f49948535eddc19fa9f5f
Autor:
Sébastien Gaujoux, Constanze Hantel, Pierre Launay, Stéphane Bonnet, Karine Perlemoine, Lucile Lefèvre, Marine Guillaud-Bataille, Felix Beuschlein, Frédérique Tissier, Jérôme Bertherat, Marthe Rizk-Rabin, Bruno Ragazzon
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55743 (2013)
ContextAdrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine neoplasm, with limited therapeutic options. Activating β-catenin somatic mutations are found in ACC and have been associated with a poor clinical outcome. In fact, activ
Externí odkaz:
https://doaj.org/article/e8baa0d2cca04cffbfe551e33e213bea